Enno Spillner - Evotec AG Insider

Evotec AG -- USA Stock  

USD 17.46  0.00  0.00%

CFO, Member of the Management Board

Mr. Enno Spillner was Chief Financial Officer and Member of the Management Board of Evotec AG since July 18, 2016. From April 2013 until June 2016 he served as Chairman of the Management Board, Chief Executive Officer and Chief Financial Officer of 4SC AG. He joined the 4SCs Management Board already in September 2005 as CFO. Before working for 4SC, Mr. Spillner was Head of Finance and Controlling at BioM AG, a German regional biotech venture fund, which he joined at the beginning of 1999. In this role he was, besides finance and controlling, responsible for managing investments in the equity portfolio and also held the position of interim Managing Director at two portfolio companies ACTIPAC Biosystems GmbH and Munich Innovative Biomaterials GmbH. In September 2001, he also assumed the position as Management Partner of BioM VC Fund. He began his career at MediaPlus Spezialagentur fr Media GmbH, Munich. Since 2014 he has also been Member of the Supervisory Board and Chairman of the Audit Committee at Nanobiotix, Paris
Age: 46  CFO Since 2016      
49 4056 0810  http://www.evotec.com
Spillner earned his Dipl.Kaufmann degree at Universitaet Bamberg.

Management Efficiency

The company has return on total asset (ROA) of 5.91 % which means that it generated profit of $5.91 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.68 % meaning that it generated $13.68 on every $100 dollars invested by stockholders.
The company has accumulated 9.4 M in total debt with debt to equity ratio (D/E) of 2.5 implying the company greatly relies on financing operations through barroing. Evotec AG has Current Ratio of 4.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Evotec AG offer drug discovery solutions to the pharmaceutical, biotechnology, and academic sectors worldwide. Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Hamburg, and employs 1,000 people.

Did you try this?

Run Pair Correlation Now
   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
Hide  View All  NextLaunch Pair Correlation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Evotec AG to your portfolio

Top Management

Evotec AG Leadership Team
Werner Lanthaler, CEO
Claus Braestrup, Executive
Michael Shalmi, Executive, MBA
Mario Polywka, COO, Ph.D
Mary Tanner, Executive
Roland Oetker, Chairman
Andreas Pinkwart, Executive
Paul Herrling, Executive, Ph.D
Colin Bond, CFO, MBA
Cord Dohrmann, Executive
Iris LoewFriedrich, Executive, Ph.D
Bernd Hirsch, Executive
Enno Spillner, CFO
Elaine Sullivan, Executive
Wolfgang Plischke, Chairman, Ph.D

Stock Performance

Evotec AG Performance Indicators